Pierluigi Porcu

15PUBLICATIONS
76CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 29, 2025
HTLV-1 and ATLL: Epidemiology, Oncogenesis, and Opportunities for Community-Informed Research in the United States.

Adrian Altieri, Sean Patrick Reilly, Abu Mansalay

|Oct 28, 2025
Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma.

Masaya Tachibana, Steven Horwitz, Eric Jacobsen

|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Rahul S Bhansali, Fredrik Ellin, Thomas Relander

|May 07, 2024
A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose.

Chetan Jeurkar, Benjamin Leiby, Shaik Rashid

|Dec 27, 2023
Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial.

Bradley Haverkos, Jasmine Zain, Manali Kamdar

|Dec 14, 2023
Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.

Zachary Braunstein, Allyson Waller, Emily Dotson

Pageof 3

Frequent Collaborators

3 joint publications

Bradley Haverkos

2 joint publications

Jasmine Zain

2 joint publications

Pamela B Allen

2 joint publications

Anjali Mishra